Finding a possible early treatment for COVID-19 [CBS News]
New York Times Company (The) (NYT)
Last new york times company (the) earnings: 2/6 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.nytco.com/investors/default.aspx
Company Research
Source: CBS News
The race to find vaccines for COVID-19 has dominated the headlines, but there's been less news about how to keep people with COVID out of the hospital. Tonight, we're going to tell you a story about one possible treatment. It's called fluvoxamine. The generic drug was developed 40 years ago as an antidepressant and has been primarily used to treat obsessive-compulsive disorder. Now, a small but ingenious clinical trial and a series of coincidences have led scientists to look closely at fluvoxamine as a possible tool to keep newly diagnosed COVID-19 patients from becoming severely ill. So how did a pill that costs 60 cents become a dark horse to treat COVID? We went to a place that knows all about long shots to find out.Golden Gate Fields is in Berkeley, California. The stands have been empty since COVID hit last year, but the races go on. There are 1,200 thoroughbreds here – trained and cared for by more than 500 people. Last November, COVID went on a rampage in the barn area where ma
Show less
Read more
Impact Snapshot
Event Time:
NYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYT alerts
High impacting New York Times Company (The) news events
Weekly update
A roundup of the hottest topics
NYT
News
- Our 15th Annual Summer Reading Contest [The New York Times]The New York Times
- Colorado passes brainwave privacy law to protect ‘what we think and feel' [Fortune]Fortune
- Empower Finance Buys Petal. What's That Mean for Petal Credit Card Users? [CNET News]CNET News
- Bringing Hope To Mothers Everywhere: The Black Fairy godmother Foundation is in need of donors for it's 7th Annual Adopt-A-Mom ProgramPR Web
- A Decade On, Silo's Zero-Waste Chef Douglas McMaster Shares Hopes, Doubts [Forbes]Forbes
NYT
Earnings
- 2/7/24 - Beat
NYT
Sec Filings
- 3/8/24 - Form ARS
- 3/8/24 - Form DEFA14A
- 3/8/24 - Form DEFA14A
- NYT's page on the SEC website